Take On Duchenne - North America
Claim This Podcastby PTC Therapeutics
Podcast Overview
<p><strong>Take on Duchenne – North America </strong></p><p> </p><p>A podcast series providing information about Duchenne muscular dystrophy (DMD), a severe neuromuscular disease. Hosted by Audrey Powell, M.D. Senior Medical Science Liaison at PTC Therapeutics, this podcast features conversations, insights and expert perspectives from medical and scientific leaders in the DMD community who, together with PTC, are committed to improving patient outcomes. </p><p> </p><p>This podcast is suitable for healthcare community and those interested in learning more about DMD. The information presented is intended to be general in nature and is not medical advice. This podcast should not replace or substitute consultation with a healthcare professional. </p><p> </p><p>This podcast is produced and funded by PTC Therapeutics in collaboration with leading experts. </p><br><p>US-DMD-0252 I 09/28/21 </p><p>Trademarks, registered or otherwise, are the property of their respective owner(s). </p><p>© 2021 PTC Therapeutics, Inc. All Rights Reserved. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
10/14/2021
11 verified contact emails on file for Take On Duchenne - North America
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
December 15, 2023
Nutrition and Duchenne
<p>In this podcast episode we are discussing the topic of Nutrition and Duchenne with our guest speaker, Dr. Kindann Fawcett, Behavioral Health Scientist, Dietitian and Caregiver to her son with Duchenne Muscular Dystrophy. Our conversation with Dr. Kindann Fawcett explores;</p><p>· the importance of healthy nutrition</p><p>· the common nutritional deficits seen in patients</p><p>· the fundamental nutritional elements for those with DMD</p><p>· weight management</p><p>· advocacy for people with Duchenne</p><p> </p><p>Tune in to learn more about this topic.</p><br><p><br></p><p><em>US-EMF-0430 I November 2023</em></p><br><p><em>Trademarks, registered or otherwise, are the property of their respective owner(s).</em></p><br><p><em>© 2023 PTC Therapeutics. All rights reserved.</em></p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
August 16, 2023
A Scientist’s Quest to Solve Duchenne Muscular Dystrophy
<p>Dr. Ellen Welch is the Chief Scientific Officer at PTC who has been researching and tackling Duchenne for more than 20 years. </p><br><p>In this episode, Dr. Welch reflects on scientific advances in the last two decades and how it has contributed to progress in the Duchenne space. </p><p> </p><p>She also explains the growing appreciation for women who are carriers, whether manifesting or not, and why it is important to ensure continuous awareness and provision of care. </p><p> </p><p>Listen to the podcast for more.</p><br><p><em>US-DMD-0305 I July 2023</em></p><br><p><em>Trademarks, registered or otherwise, are the property of their respective owner(s).</em></p><br><p><em>© 2023 PTC Therapeutics. All rights reserved.</em></p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
May 1, 2023
A Mother and Carrier of Duchenne Muscular Dystrophy Shares Her Journey
<p><strong>A Mother and Carrier of Duchenne Muscular Dystrophy Shares Her Journey </strong></p><br><p>Elizabeth’s journey with DMD began when her son was diagnosed at the age of five. </p><br><p>In this episode, Elizabeth reflects on the diagnosis of her son, her daughter’s and her own carrier diagnosis, family life, her coping mechanisms and management of the disease. Although her and her family’s lives have been impacted by DMD, her future outlook is positive and inspiring. </p><br><p><em>US-DMD-0304 I April 2023 </em></p><br><p><em>PTC Therapeutics has provided financial compensation to Elizabeth Floyd for the time to conduct this interview. </em></p><br><p><em>Trademarks, registered or otherwise, are the property of their respective owner(s). </em></p><br><p><em><span class="ql-cursor"></span>© 2023 PTC Therapeutics, Inc. All Rights Reserved</em></p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
10 total episodes available
Deep-dive analytics for Take On Duchenne - North America
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Take On Duchenne - North America ?
<p><strong>Take on Duchenne – North America </strong></p><p> </p><p>A podcast series providing information about Duchenne muscular dystrophy (DMD), a severe neuromuscular disease. Hosted by Audrey Powell, M.D. Senior Medical Science Liaison at PTC Therapeutics, this podcast features conversations, insights and expert perspectives from medical and scientific leaders in the DMD community who, together with PTC, are committed to improving patient outcomes. </p><p> </p><p>This podcast is suitable for healthcare community and those interested in learning more about DMD. The information presented is intended to be general in nature and is not medical advice. This podcast should not replace or substitute consultation with a healthcare professional. </p><p> </p><p>This podcast is produced and funded by PTC Therapeutics in collaboration with leading experts. </p><br><p>US-DMD-0252 I 09/28/21 </p><p>Trademarks, registered or otherwise, are the property of their respective owner(s). </p><p>© 2021 PTC Therapeutics, Inc. All Rights Reserved. </p><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p> - How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Information about guest appearances is not available.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.